A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

(2018) Gianluca Ianiro et al.   United European Gastroenterology Journal

Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

(2017) Stephan J. Ott et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

(2016) Alexander Khoruts et al.   Clinical Gastroenterology and Hepatology

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation

(2016) Harry Sokol et al.   DIGESTIVE AND LIVER DISEASE

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

(2016) Monika Fischer et al.   INFLAMMATORY BOWEL DISEASES

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection

(2016) Christine H. Lee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fecal microbial transplantation in a pediatric case of recurrentClostridium difficileinfection and specific antibody deficiency

(2016) Paxton Loke et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Fecal microbiota transplantation for recurrentClostridium difficileinfection in hematopoietic stem cell transplant recipients

(2016) B.J. Webb et al.   Transplant Infectious Disease

Microbiome changes associated with sustained eradication ofClostridium difficileafter single faecal microbiota transplantation in children with and without inflammatory bowel disease

(2015) S. K. Hourigan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection

(2015) G. Cammarota et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection

(2015) Bruce E Hirsch et al.   BMC INFECTIOUS DISEASES

Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma

(2015) C Mittal et al.   BONE MARROW TRANSPLANTATION

Pulsed faecal microbiota transplantation for recalcitrant recurrent Clostridium difficile infection

(2015) R.J. Porter   CLINICAL MICROBIOLOGY AND INFECTION

A Case of Toxic Megacolon Caused by Clostridium difficile Infection and Treated with Fecal Microbiota Transplantation

(2015) Tae-Geun Gweon et al.   Gut and Liver

Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile

(2015) Amar Mandalia et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Fecal Microbiota Transplantation for Recurrent C. difficile Infection in a Patient with Chronic Refractory Ulcerative Colitis

(2015) A. Aratari et al.   Journal of Crohns & Colitis

Fecal Microbiota Transplantation Via Nasogastric Tube for Recurrent Clostridium difficile Infection in Pediatric Patients

(2015) Matthew P. Kronman et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant

(2015) Joshua Stripling et al.   Open Forum Infectious Diseases

Fecal microbiota transplantation for Clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patient

(2014) Marko Schünemann et al.   AIDS

Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

(2014) Colleen R Kelly et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal Microbiota Transplantation for RefractoryClostridium difficileColitis in Solid Organ Transplant Recipients

(2014) R. J. Friedman-Moraco et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Fecal microbiota transplant after hematopoietic SCT: report of a successful case

(2014) C G de Castro et al.   BONE MARROW TRANSPLANTATION

The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema

(2014) C. H. Lee et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Donor fecal transfer for recurrent Clostridium difficile-associated diarrhea in heart transplantation

(2014) Philipp Ehlermann et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractoryClostridium difficileinfection in a patient with relapsed aggressive B-cell lymphoma

(2014) Jason A. Trubiano et al.   LEUKEMIA & LYMPHOMA

Fecal Microbiota Transplantation in Children With Recurrent Clostridium difficile Infection

(2014) Anne Pierog et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

(2014) Carolyn D. Alonso et al.   Current Infectious Disease Reports

Fecal Microbiota Therapy for RecurrentClostridium difficileInfection in HIV-Infected Persons

(2013) Latesha Elopre et al.   ANNALS OF INTERNAL MEDICINE

Resolution of Severe Clostridium difficile Infection Following Sequential Fecal Microbiota Transplantation

(2013) Alexa R. Weingarden et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection

(2013) Rodrigo Quera et al.   Journal of Crohns & Colitis

Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease

(2013) George H. Russell et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

(2012) Lawrence J Brandt et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal microbiome transplantation for recurrent Clostridium difficile infection: Report on a case series

(2012) Timothy A. Rubin et al.   ANAEROBE

Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report

(2012) Mini Kamboj et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Fecal microbiota transplantation for fulminantClostridium difficileinfection in an allogeneic stem cell transplant patient

(2012) K. Neemann et al.   Transplant Infectious Disease

Treating Clostridium difficile Infection With Fecal Microbiota Transplantation

(2011) Johan S. Bakken et al.   Clinical Gastroenterology and Hepatology

Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection

(2011) Eero Mattila et al.   GASTROENTEROLOGY

Efficacious outcome employing fecal bacteriotherapy in severe Crohn’s colitis complicated by refractory Clostridium difficile infection

(2011) C. A. Duplessis et al.   INFECTION

Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection

(2010) Michael S. Silverman et al.   Clinical Gastroenterology and Hepatology

Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy

(2010) Sonia S. Yoon et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

(2010) Kjetil Garborg et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

(2009) S. SCHNEEWEISS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE